Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses

Skin Mycoses Clinical Trial

Official title:

Observational Study of the Efficacy, Safety and Tolerance of Travogen Cream (Isoconazole) and Travocort Cream (Isoconazole, Diflurcortolone) in the Treatment of Patients With Local Skin Mycosis of Various Etiology and Localization

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00722189
• Other study ID #: 2008/01850
• Status: Completed
• Start date: July 2008
• Est. completion date: February 2009

Study information

• Verified date: March 2015
• Source: LEO Pharma
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

An assessment of the efficacy and safety of Travogen cream and Travocort cream in the treatment of local skin mycoses

Recruitment information / eligibility

• Status: Completed
• Enrollment: 900
• Est. completion date: February 2009
• Est. primary completion date: January 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Diagnosis of skin mycosis

Exclusion Criteria:

• Allergies to study medication

Related Conditions & MeSH terms

• Dermatomycoses
• Mycoses
• Skin Mycoses

Locations

Country	Name	City	State
Russian Federation	Kashkin Clinical Research Mycological Institute	St Petersburg

Sponsors (2)

Lead Sponsor	Collaborator
LEO Pharma	Bayer

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Efficacy of Travogen / Travocort in the treatment of skin mycoses / Travogen Cream and Travocort Cream will be prescribed by a physician		Baseline to end of study
Secondary	Patient satisfaction		Baseline to end of study